Education

1985
Bachelor of Science, Psychology
Louisiana State University-Baton Rouge, LA

1993
Master of Social Work
New Mexico Highlands University

2006
Doctor of Experimental Psychology
University of New Mexico

2006-2008
Postdoctoral Fellowship
Geriatric Psychiatry Research
Columbia University-New York, NY

Publications

Daniyell Thomason, Morganne Manuel, Shannin Moody, Jesus Lovera, Brian Copeland, Deidre Devier. The Symbol Digit Modalities Test as a screening tool for cognitive impairment in Parkinson’s Disease. Clinical Parkinsonism and Related Disorders.

Randy L Rosamond, Diane W Wardell, Gloria P Giarratano, Deidre J Devier, Qingzhao Yu. Healing Touch as a Method for Supporting Holistic Nursing Practice: A Cluster Randomized Controlled Trial. 2025 J Holist Nurs June 11. PMID: 40495640.

Shannin N Moody, Morganne Manuel, Auriel Willette, Elizabeth Shirtcliff, Brian Copeland, Jesus Lovera, Deidre Devier. 2024 The intersection of race and sex on the clinical and cognitive progress of multiple sclerosis. J Neurol Sci 2024 Nov 15:466:123260. PMID: 39476715. PMCID: PMC11587816. 

Randy L Rosamond, Gloria Giarratano, Susan Orlando, Jane Sumner, Deidre Devier, Lee S McDaniel, Diane Wind Wardell. 2023 Healing Touch: A Strategy for Acute Care Nurses/ Stress Reduction. J Holist Nurs Dec;41(4):2347-359. PMID: 36714962. 

Morganne Manuel, Shannin Moody, Logan Hilton, Brian Copeland, Deidre J. Devier (co-last author), Jesus F Lovera. 2022 King Devick Test and MoCA can be used in Routine Clinical Visits to Help Detect Cognitive Impairment in Multiple Sclerosis. Journal of Multiple Sclerosis, Vol.9, Issue 4, 001-006.

 

Research

My area of research is clinical, exploring the negative cognitive effects of neurodegenerative disorders such as Multiple Sclerosis, Parkinsons’ Disease, and dementia through clinical research and neuroimaging

Students can work on the following:

• Conducting clinical research protocols that involve extensive interactions with patients with neurodegenerative disorders such as Multiple Sclerosis, Parkinson’s Disease, Huntington Disease, and Dementia
• Administration of neuropsychological assessment tools to measure cognitive decline
• Access to research and MRI brain scans for analysis